Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
View corresponding page on italian website CURASEPT.IT
Curasept Softline

THE TOOTHBRUSH IS THE 1ST TOOL FOR SMILE CARE.

SOFTLINE toothbrushes are best for gum inflammation and irritation.

The unique SOFT TOUCH SYSTEM technology, differentiates them by the high quality of polyester filaments combined with the degree of softness and density, features that ensure their superior cleaning ability without causing damage to gums and dental tissues.

MAXIMUM EFFECTIVENESS, MAXIMUM ATRAUMATICITY.

Curasept Softline Toothbrush

Toothbrush with hard and sparse bristles

MADE IN ITALY EXCELLENCE

All Curasept toothbrushes combine Made in Italy engineering excellence with Curasept’s expertise in oral hygiene.

The choice to produce in Italy allows control of the production chain and ensures compliance with all applicable regulations.

1-SAFETY GUARANTEED

The head is rounded
to avoid trauma
to the gums

 

2-THE SHAPE OF EFFICIENCY

The anatomical shape of the head, being thinner in the front, allows the toothbrush to easily reach less accessible parts of the mouth.

3-CORRECTIVE MOVEMENT

The handle has a moderate flexibility specifically designed to alleviate any excessive pressure applied incorrectly.

4-MORE CONTROL

The rubber insert on the front helps position the toothbrush correctly and facilitates the control of movements.

5-SUPERIOR HANDLING

The rubber also present on the back of the toothbrush allows for better handle grip.

6-VISUAL IDENTIFICATION

Each toothbrush has a laser engraving that indicates the model and reference.

DISCOVER THE FULL RANGE

CURASEPT SOFTLINE MAXI SOFT TOOTHBRUSH 010
CURASEPT SOFTLINE MEDICAL TOOTHBRUSH
CURASEPT SOFTLINE SOFT TOOTHBRUSH 015
CURASEPT SOFTLINE TOOTHBRUSH – MEDIUM 017
CURASEPT SOFTLINE TOOTHBRUSH EXTRA SOFT 012

THE FIRST NON-STAINING CHLORHEXIDINE

The first Curasept mouthwashes and toothpastes with Chlorhexidine featuring A.D.S.® – Anti Discoloration System, an innovative, patented, and clinically tested system that reduces the appearance of yellow-brown spots on the teeth, which is the main side effect of Chlorhexidine.

A.D.S.® inhibits the two chemical reactions leading to pigmentation, without affecting the antiplaque activity of Chlorhexidine. 

Curasept ADS

small_c_popup.png

Vuoi accedere ai contenuti Extra? Registrati o fai Login per accedere ai contenuti a te dedicati: articoli, video ,schede… e tanto altro!

Non sei registrato?
Clicca il pulsante qui sotto. La registrazione è gratuita.

Quality Policy

The Quality for CURASEPT S.p.A. is an essential condition to put itself successfully on the market, considering its characteristics and evolution.

The development of the Company and its profit are insured by the continuous search for quality towards excellence through the continuous improvement of its processes and the search for partners with quality systems adapted to our standards.

The Company aims to increase the customer satisfaction through the application of its Quality Management System, including the processes to improve the system and to ensure the compliance with the customer and applicable regulatory requirements.

For this purpose, the Company performs specific risks and opportunities assessment activities, connected to the context, stakeholders and related objectives, in order to identify the areas of system improvements and to define the appropriate actions for the risk control and mitigation and strengthening of its Quality System.

The starting point for the implementation of this policy is the pursuit of the following objectives:

  • Define and implement a Quality Management System according to 9001:2015+A1:2024 e UNI CEI EN ISO 13485:2021 regulation, as Manufacturer of Medical Devices;
  • Define and implement a system of procedures and operating instructions in harmony with the Directive 93/42/CEE, the Regulation (UE) 2017/745 and the Regulation (UE) 2023/607 for the applicable parts and subsequent changes and integrations, which satisfy the essential requirements set out in Annex I;
  • Define and implement a system of procedures in harmony with the Directive 2010/84, the Regulation 1235/2010, the Implementation Regulation n. 520/2012 and in accordance with the objectives of “module I – “Good Vigilance Practices” (GVP);
  • Establish and formalize the business organizational structure with the subdivision into areas of competences;
  • Clarify roles and responsibilities of business functions;
  • Define strategies and objectives and assign human and material resources for their achievement;
  • Define accurately business processes and related performance factors;
  • Ensure compliance with qualitative, quantitative and temporal requirements;
  • Constantly monitor the level of adequacy of the system with reference to regulations and laws;
  • Promote initiatives in order to improve the process of motivational and professional growth of human resources, considered as critical resources for future business developments;
  • Ensure the commitment to the satisfaction of requirements and the maintenance of effectiveness of the Quality Management System.

These objectives can be realized thanks to the involvement of the whole Company personnel.

In particular, the Managers of each Function provide their contribution so that the suggested improvements can be proposed to the General Direction, so that the Quality Policy can be a priority element in the choice of business qualitative and organizational strategies.

The involvement of the whole personnel in the improvement of internal and external processes should be aimed at reducing non-compliance and internal and external costs of non-quality; for this reason all employees should feel themselves committed in pursuing this policy.

Training courses, for all business levels, are promoted and planned by the General Direction in order to keep the personnel constantly up to date on the improvements performed for the processes.

The Quality Manual, which is distributed via the SistemaQualità to all process managers and the General Director, should represent a work tool for all Managers and their personnel for the implementation of the Quality Policy.

April 2025

General Direction